Next Article in Journal
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
Next Article in Special Issue
Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
Previous Article in Journal
The Role of Non-Steroidal Anti-Inflammatory Drugs in Renal Colic
Previous Article in Special Issue
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 3
Issue 5
10.3390/ph3051311
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Prospects for the Use of ATR Inhibitors to Treat Cancer

by
Jill M. Wagner
and
Scott H. Kaufmann
*
Division of Oncology Research, College of Medicine, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(5), 1311-1334; https://doi.org/10.3390/ph3051311
Submission received: 31 March 2010 / Revised: 12 April 2010 / Accepted: 19 April 2010 / Published: 28 April 2010
(This article belongs to the Special Issue Protein Kinase Inhibitors)
Browse Figures
Versions Notes

Abstract

ATR is an apical kinase in one of the DNA-damage induced checkpoint pathways. Despite the development of inhibitors of kinases structurally related to ATR, as well as inhibitors of the ATR substrate Chk1, no ATR inhibitors have yet been developed. Here we review the effects of ATR downregulation in cancer cells and discuss the potential for development of ATR inhibitors for clinical use.
Keywords: Replication checkpoint; ATR; ATM; chemotherapy; Chk1 Replication checkpoint; ATR; ATM; chemotherapy; Chk1

Share and Cite

MDPI and ACS Style

Wagner, J.M.; Kaufmann, S.H. Prospects for the Use of ATR Inhibitors to Treat Cancer. Pharmaceuticals 2010, 3, 1311-1334. https://doi.org/10.3390/ph3051311

AMA Style

Wagner JM, Kaufmann SH. Prospects for the Use of ATR Inhibitors to Treat Cancer. Pharmaceuticals. 2010; 3(5):1311-1334. https://doi.org/10.3390/ph3051311

Chicago/Turabian Style

Wagner, Jill M., and Scott H. Kaufmann. 2010. "Prospects for the Use of ATR Inhibitors to Treat Cancer" Pharmaceuticals 3, no. 5: 1311-1334. https://doi.org/10.3390/ph3051311

APA Style

Wagner, J. M., & Kaufmann, S. H. (2010). Prospects for the Use of ATR Inhibitors to Treat Cancer. Pharmaceuticals, 3(5), 1311-1334. https://doi.org/10.3390/ph3051311

Article Metrics

Back to TopTop